In mouse models, allele-specific silencing of mutant MYH6 suppressed the development of HCM [76], and exon skipping therapy to skip a mutated exon in the MYBPC3 gene using ASOs reduced levels of incorrectly spliced messenger RNA, producing stable functional proteins and preventing cardiac hypertrophy [77]. The gene discussed is MYBPC3; the disease is cardiac hypertrophy.